WP
KRRO icon

Woodline Partners’s Korro Bio KRRO Stock Holding History

Woodline Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,094
Closed -$2.4M – 1074
2025
Q3 		$2.4M Hold
50,094
– – 0.01% 700
2025
Q2 		$626K Hold
50,094
– – ﹤0.01% 838
2025
Q1 		$872K Sell
50,094
-52,000
-51% -$1.54M 0.01% 776
2024
Q4 		$3.89M Buy
+102,094
New +$5.25M 0.03% 534

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Woodline Partners's KRRO Position: Q4 2025 in Review

Woodline Partners sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 50,094 shares — an estimated $2.4M sold.

Woodline Partners first reported a position in KRRO in Q4 2024 and held it in 4 quarters. The position peaked at $3.89M in Q4 2024. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

  • Woodline Partners reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
  • Woodline Partners sold 50,094 Korro Bio shares in Q4 2025, an estimated $2.4M.
  • Woodline Partners first reported a position in Korro Bio in Q4 2024 and held it in 4 quarters.
  • Woodline Partners's Korro Bio position peaked at $3.89M in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.